JUAN DIEGO GUARIMATA; MARTIN LAVECCHIA

In Silico Study of FDA-Approved Drugs on Leishmania infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis

28th International Electronic Conference on Synthetic Organic Chemistry (ECSOC-27)

Año: 2024;